XLV SOLACI Regional Sessions– 15° Andean Region.
October 6, 7 & 8, 2022
The XLV SOLACI Regional Sessions (15th Andean Region) were held on October 6,...
The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...
This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT).
After one-year follow-up, there were no...
Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.
Based on the CHOICE-CLOSURE and MASH...